Close

Teneliximab (TAB-262)

DESCRIPTION CATALOG # SIZE PRICE
Anti-Human CD40 Therapeutic Antibody TAB-262 1mg Please Inquiry

PRODUCT INFORMATION

  • Product Overview
  • Recombinant monoclonal antibody to CD40. Teneliximab is a chimeric monoclonal antibody binding to the immune stimulatory protein CD40.
  • Target
  • CD40
  • Type
  • IgG1
  • Immunogen
  • Recombinant protein of extracellular domain of CD40.
  • Species Reactivity
  • Human
  • Expression Host
  • CHO
  • Applications
  • Suitable for use in WB, IP, IF, FuncS, FC, Neut, ELISA and most other immunological methods.
  • CAS
  • 299423-37-3
  • Specificity
  • Tested positive against native human antigen.
  • Protein Construction
  • Immunoglobulin G1, anti-(human CD40 (antigen)) (human-mouse monoclonal chi220 γ1-chain), disulfide with human-mouse monoclonal chi220 light chain, dimer
  • Purity
  • >95.0% as determined by analysis by SDS-PAGE.
  • Size
  • 1mg
  • Storage
  • Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples.

BACKGROUND

  • Antigen Description
  • Receptor for TNFSF5/CD40LG.
  • Function
  • enzyme binding; protein binding; receptor activity; signal transducer activity;
  • Synonyms
  • CD40; CD40 molecule, TNF receptor superfamily member 5; TNFRSF5, tumor necrosis factor receptor superfamily, member 5; tumor necrosis factor receptor superfamily member 5; Bp50; p50; CD40L receptor; CD40 type II isoform; B cell-associated molecule; B cell surface antigen CD40; B-cell surface antigen CD40; CD40 antigen (TNF receptor superfamily member 5); tumor necrosis factor receptor superfamily, member 5; nerve growth factor receptor-related B-lymphocyte activation molecule; CDW40; TNFRSF5; MGC9013;

Related Products

Online Inquiry

Verification code
Click image to refresh the verification code.

CONTACT US

45-1 Ramsey Road, Shirley, NY 11967, USA
Call us at:
USA: 1-631-381-2994
Europe: 44-207-097-1828
Fax: 1-631-207-8356
Email:
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us